Publication | Closed Access

Identification of new anti-mycobacterial agents based on quinoline-isatin hybrids targeting enoyl acyl carrier protein reductase (InhA)

Antimicrobial SusceptibilityNew Anti-mycobacterial AgentsMedicineAntibiotic AdjuvantSynthetic BiologyAntibacterial AgentAntimicrobial ChemotherapyMicrobiologyQuinoline-isatin HybridsAntimicrobial CompoundPharmacologyAntimicrobial ResistanceDrug DiscoveryDrug Resistance